China Life revenue jumps as insurer bets on AI and chips
First-half revenue reached 434.3 billion yuan as the world's largest life insurer by market value pledges more money for AI, chips and biotech.
Illustration: the financial district of a Chinese coastal city at dawn, with industrial halls visible across the river.
China Life posted first-half 2026 revenue of 434.3 billion yuan (US$64.6 billion), up 81.5 percent year on year, and says it will put more capital into AI, semiconductors and biotechnology.
At a glance
- First-half 2026 revenue: 434.3 billion yuan (US$64.6 billion), up 81.5 percent from a year earlier.
- Net profit: 134.5 billion yuan, described in the report as a rise of more than 228 percent.
- Stated priorities: AI, semiconductors, healthcare, biotechnology and next-generation infrastructure.
- Already in the portfolio: memory chipmaker ChangXin Memory Technologies.
- Vice-president Liu Hui calls investment tied to „new quality productive forces“ a key growth driver.
China Life Insurance reported first-half 2026 revenue of 434.3 billion yuan (US$64.6 billion) and said it plans to steer more capital toward artificial intelligence, semiconductors and biotechnology, according to the South China Morning Post's account of the company's interim results.
What the results show
Revenue at the Shanghai- and Hong Kong-listed insurer rose 81.5 percent from a year earlier. Net profit came in at 134.5 billion yuan, which the report describes as a gain of more than 228 percent. China Life is the world's largest life insurer by market value.
Where the money is headed
The named priorities are AI, semiconductors, healthcare, biotechnology and next-generation infrastructure. Vice-president Liu Hui framed investment tied to „new quality productive forces“ as the growth driver best placed to deliver differentiated returns. The insurer also says it wants to act as a long-term partner to innovative companies.
The chip angle
Exactly one holding is named: memory chipmaker ChangXin Memory Technologies is already in the portfolio. Insurance capital matters in China's chip industry because fabs and process development need funding that stretches over many years. No other technology stakes appear in the report.
What is not established
The report gives no figure for how much capital will go into these sectors, and no timeline. Premium income, total investment assets, investment yield and dividend are absent from the version available to us. No second independent newsroom had confirmed these numbers at the time of writing, so this account rests on a single source.
FAQ
How much revenue did China Life report for the first half of 2026?
434.3 billion yuan, or US$64.6 billion. That is 81.5 percent more than in the same period a year earlier.
Which sectors does China Life want to invest in?
AI, semiconductors, healthcare, biotechnology and next-generation infrastructure. The company did not disclose how much it plans to commit.
Does China Life already hold a stake in a chipmaker?
Yes. Memory chipmaker ChangXin Memory Technologies is in its portfolio according to the report, though the size of the stake was not given.
